Patents by Inventor Anna K. Fulbright

Anna K. Fulbright has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9885092
    Abstract: Provided are nucleic acids capable of hybridizing to HPV 16 and/or HPV 18 nucleic acids, in particular, mRNA encoding E2 and E6-7 gene products. Such nucleic acids are useful in methods of isolating RNA from a biological sample, methods and means for determining the presence of particular RNA splice-form variants in a biological sample, methods and means for determining the relative ratio of RNA ratios in a biological sample, methods and means for predicting the progression of precancerous cervical lesions, and methods and means for detecting disruption of genes or gene expression.
    Type: Grant
    Filed: February 23, 2012
    Date of Patent: February 6, 2018
    Assignee: QIAGEN GAITHERSBURG INC.
    Inventors: Brian Lowe, Anna K. Fulbright, Irina Nazarenko
  • Patent number: 9797000
    Abstract: Provided are methods of isolating RNA from a biological sample, methods and means for determining the presence of particular RNA splice-form variants in a biological sample, methods and means for determining the relative ratio of RNA ratios in a biological sample, and methods and means for predicting the progression of precancerous cervical lesions.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: October 24, 2017
    Assignee: QIAGEN GAITHERSBURG INC.
    Inventors: Brian Lowe, Anna K. Fulbright, Irina Nazarenko
  • Publication number: 20120322049
    Abstract: Provided are nucleic acids capable of hybridizing to HPV 16 and/or HPV 18 nucleic acids, in particular, mRNA encoding E2 and E6-7 gene products. Such nucleic acids are useful in methods of isolating RNA from a biological sample, methods and means for determining the presence of particular RNA splice-form variants in a biological sample, methods and means for determining the relative ratio of RNA ratios in a biological sample, methods and means for predicting the progression of precancerous cervical lesions, and methods and means for detecting disruption of genes or gene expression.
    Type: Application
    Filed: February 23, 2012
    Publication date: December 20, 2012
    Applicant: QIAGEN GAITHERSBURG INC.
    Inventors: Brian LOWE, Anna K. FULBRIGHT, Irina NAZARENKO
  • Publication number: 20120021460
    Abstract: A method for isothermal amplification of a target nucleic acid sequence is disclosed. The target nucleic acid is amplified by an enzyme with helicase activity and an enzyme with reverse transcriptase activity and DNA-dependant DNA polymerase activity. Also disclosed is a kit for isothermal amplification of a target nucleic acid sequence, including HPV nucleic acids. The kit comprises a first enzyme with helicase activity and a second enzyme having both reverse transcriptase activity and DNA-dependant DNA polymerase activity.
    Type: Application
    Filed: January 7, 2011
    Publication date: January 26, 2012
    Applicant: QIAGEN GAITHERSBURG INC.
    Inventors: Brian LOWE, Anna K. Fulbright
  • Publication number: 20100311039
    Abstract: Provided are methods of isolating RNA from a biological sample, methods and means for determining the presence of particular RNA splice-form variants in a biological sample, methods and means for determining the relative ratio of RNA ratios in a biological sample, and methods and means for predicting the progression of precancerous cervical lesions.
    Type: Application
    Filed: April 30, 2010
    Publication date: December 9, 2010
    Applicant: QIAGEN GAITHERSBURG INC.
    Inventors: Brian Lowe, Anna K. Fulbright, Irina Nazarenko